BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 7915270)

  • 21. Fluoxetine versus placebo in depressed alcoholic cocaine abusers.
    Cornelius JR; Salloum IM; Thase ME; Haskett RF; Daley DC; Jones-Barlock A; Upsher C; Perel JM
    Psychopharmacol Bull; 1998; 34(1):117-21. PubMed ID: 9564208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluoxetine and concomitant centrally acting medication use during clinical trials of depression: the absence of an effect related to agitation and suicidal behavior.
    Wernicke JF; Sayler ME; Koke SC; Pearson DK; Tollefson GD
    Depress Anxiety; 1997; 6(1):31-9. PubMed ID: 9394873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychopharmacological treatment response of patients with a DSM-III diagnosis of dysthymic disorder.
    Bakish D; Ravindran A; Hooper C; Lapierre Y
    Psychopharmacol Bull; 1994; 30(1):53-9. PubMed ID: 7972630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sexual activity among HIV-seropositive gay men seeking treatment for depression.
    Wagner GJ; Rabkin JG; Rabkin R
    J Clin Psychiatry; 1993 Dec; 54(12):470-5. PubMed ID: 7903966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder.
    Stark P; Hardison CD
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):53-8. PubMed ID: 3882682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of the efficacy and tolerability of fluoxetine in major depression, Multicenter clinical study].
    Cabras PL; Enriques E; Casini A; Paoletti C; Zagnoni P
    Minerva Psichiatr; 1991; 32(2):93-101. PubMed ID: 1870418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relapse in patients on long-term fluoxetine treatment: response to increased fluoxetine dose.
    Fava M; Rappe SM; Pava JA; Nierenberg AA; Alpert JE; Rosenbaum JF
    J Clin Psychiatry; 1995 Feb; 56(2):52-5. PubMed ID: 7852252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of imipramine on depression and immune status in a sample of men with HIV infection.
    Rabkin JG; Harrison WM
    Am J Psychiatry; 1990 Apr; 147(4):495-7. PubMed ID: 1969246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of major depression in HIV-seropositive men. HIV Neurobehavioral Research Center Group.
    Zisook S; Peterkin J; Goggin KJ; Sledge P; Atkinson JH; Grant I
    J Clin Psychiatry; 1998 May; 59(5):217-24. PubMed ID: 9632030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluoxetine in patients with major depressive disorder--a responder analysis.
    Klieser E; Lehmann E; Heinrich K
    Pharmacopsychiatry; 1995 Jan; 28(1):14-9. PubMed ID: 7746839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluoxetine treatment of nonparaphilic sexual addictions and paraphilias in men.
    Kafka MP; Prentky R
    J Clin Psychiatry; 1992 Oct; 53(10):351-8. PubMed ID: 1429474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylphenidate as a treatment for depression in acquired immunodeficiency syndrome: an n-of-1 trial.
    White JC; Christensen JF; Singer CM
    J Clin Psychiatry; 1992 May; 53(5):153-6. PubMed ID: 1592840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparative trial of a new antidepressant, fluoxetine.
    Levine S; Deo R; Mahadevan K
    Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():41-5. PubMed ID: 2644339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bipolar disorder: clinical trials with fluoxetine].
    Ambrosio LA; Buccomino D; Filippo A; Filippo P; Marchese G; Barrese E; Paoletti C; Colonna CV
    Minerva Psichiatr; 1992; 33(4):305-12. PubMed ID: 1297908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pharmacotherapy of depressive illness in adolescence: I. An open label trial of imipramine.
    Strober M; Freeman R; Rigali J
    Psychopharmacol Bull; 1990; 26(1):80-4. PubMed ID: 2196630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Depression, altered immunity, and health: clinical implications for psychoimmunologic processes.
    Keller SE; Schleifer SJ; Bartlett JA
    Res Publ Assoc Res Nerv Ment Dis; 1990; 68():179-82. PubMed ID: 1970190
    [No Abstract]   [Full Text] [Related]  

  • 37. Stability of mood despite HIV illness progression in a group of homosexual men.
    Rabkin JG; Goetz RR; Remien RH; Williams JB; Todak G; Gorman JM
    Am J Psychiatry; 1997 Feb; 154(2):231-8. PubMed ID: 9016273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Doxepin as adjunctive therapy for depressed methadone maintenance patients: a double-blind study.
    Titievsky J; Seco G; Barranco M; Kyle EM
    J Clin Psychiatry; 1982 Nov; 43(11):454-6. PubMed ID: 7174622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia.
    Hellerstein DJ; Yanowitch P; Rosenthal J; Samstag LW; Maurer M; Kasch K; Burrows L; Poster M; Cantillon M; Winston A
    Am J Psychiatry; 1993 Aug; 150(8):1169-75. PubMed ID: 8328559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial.
    Gillin JC; Rapaport M; Erman MK; Winokur A; Albala BJ
    J Clin Psychiatry; 1997 May; 58(5):185-92. PubMed ID: 9184611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.